Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Cancers|July 24, 2021
Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer CellsPenn Muluhngwi, Carolyn M KlingeMolecular and Cellular Endocrinology|February 7, 2017
Identification of miRNAs as biomarkers for acquired endocrine resistance in breast cancerPenn Muluhngwi, Carolyn M KlingeEndocrine-Related Cancer|September 9, 2015
Roles for miRNAs in endocrine resistance in breast cancerPenn Muluhngwi, Carolyn M KlingeGenes|July 29, 2025
Evaluating the Diagnostic Utility of dd-cfDNA in Renal Allograft Surveillance: A Single-Center PerspectiveAja Aravamudhan, Kira Krug, Michelle Stoffel, et al.The Journal of Applied Laboratory Medicine|March 29, 2025
The Effect of Clinical Decision Support Intervention on Monitoring for Donor Specific AntibodiesAja Aravamudhan, Carolynn Scalf, Michael P Greenwood, et al.Pharmacogenomics|April 16, 2019
Cell-free DNA diagnostics: current and emerging applications in oncologyPenn Muluhngwi, Roland Valdes, Rafael Fernandez-Botran, et al.The Journal of Applied Laboratory Medicine|October 30, 2019
Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested PlatformPenn Muluhngwi, Cierra N Sharp, Nicole Pozzi, et al.Scientific Reports|July 14, 2017
The miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cellsPenn Muluhngwi, Negin Alizadeh-Rad, Stephany L Vittitow, et al.Molecular and Cellular Endocrinology|February 1, 2017
Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cellsPenn Muluhngwi, Kirsten Richardson, Joshua Napier, et al.The Journal of Applied Laboratory Medicine|March 6, 2021
A Shared Diagnostic Stewardship Approach toward Improving Autoimmune Encephalopathy Send-out Testing UtilizationCierra N Sharp, Anita Fletcher, Penn Muluhngwi, et al.Pageof 2